Literature DB >> 32307498

Protective effect of ferulic acid on STZ-induced diabetic nephropathy in rats.

Min-You Qi1, Xu-Tao Wang, Hui-Lin Xu, Zhang-Liang Yang, Yin Cheng, Bin Zhou.   

Abstract

Diabetic nephropathy (DN) is a major and severe complication of diabetes mellitus. Ferulic acid (FA), a phenolic compound widespread in fruits and plants, displays a variety of pharmacological activities including regulating blood glucose and lipids, anti-oxidation, anti-inflammation and anti-fibrosis. The study was aimed to investigate the renal protective effects of FA on diabetic rats and elucidate the underlying mechanisms. FA (100 mg kg-1, i.g., once a day) was administered to DN rats for 8 weeks. The organ coefficient of kidneys was calculated. Levels of UP, BUN, Cr, FBG, TC and TG in serum were measured. Activities of SOD, CAT and GPx and the content of MDA in renal tissues were assayed. Pathological changes in renal tissues were observed by HE staining, PAS staining, PASM staining, Masson staining and transmission electron microscopy. p-NF-κB p65, TNF-α, TGF-β1, collagen IV, nephrin and podocin protein expressed in renal tissues were determined by immunohistochemistry and western blotting. Results showed that FA significantly improved the kidney organ coefficient, decreased the UP, BUN, Cr, FBG, TC and TG levels in serum, increased SOD, CAT and GPx activities, reduced MDA content in renal tissues and alleviated pathological injury of the renal tissues. What's more, long-term treatment with FA considerably down-regulated the expressions of p-NF-κB p65, TNF-α, TGF-β1 and collagen IV proteins, and up-regulated the expressions of nephrin and podocin proteins in renal tissues. FA could be a renoprotective agent by attenuating oxidative stress, inflammation, and fibrosis, as well as improving podocyte injury in STZ-induced DN rats.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32307498     DOI: 10.1039/c9fo02398d

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  6 in total

1.  Tangshenning Attenuates High Glucose-Induced Podocyte Injury via Restoring Autophagy Activity through Inhibiting mTORC1 Activation.

Authors:  Jiayi Xu; Xiaomeng Shan; Chunwei Chen; Yanbin Gao; Dawei Zou; Xiaolei Wang; Tao Wang; Yimin Shi
Journal:  J Diabetes Res       Date:  2022-06-28       Impact factor: 4.061

2.  Yiqi Huoxue Recipe Regulates Autophagy through Degradation of Advanced Glycation End Products via mTOR/S6K1/LC3 Pathway in Diabetic Nephropathy.

Authors:  Liang Chen; Linghao Dai; Yi Liu; Xinyue Li; Hui Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-09       Impact factor: 2.629

3.  Therapeutic Potentials of Colocasia affinis Leaf Extract for the Alleviation of Streptozotocin-Induced Diabetes and Diabetic Complications: In vivo and in silico-Based Studies.

Authors:  Manik Chandra Shill; Asim Kumar Bepari; Mahi Khan; Zarin Tasneem; Tania Ahmed; Md Asif Hasan; Md Jahir Alam; Murad Hossain; Md Ashrafur Rahman; Shazid Md Sharker; Masum Shahriar; Ghazi Muhammad Sayedur Rahman; Hasan Mahmud Reza
Journal:  J Inflamm Res       Date:  2021-02-19

4.  Forsythoside A Alleviates High Glucose-Induced Oxidative Stress and Inflammation in Podocytes by Inactivating MAPK Signaling via MMP12 Inhibition.

Authors:  Xiaohong Quan; Huihui Liu; Dongmei Ye; Xinling Ding; Xiulan Su
Journal:  Diabetes Metab Syndr Obes       Date:  2021-04-28       Impact factor: 3.168

5.  Effects of Shenkang Pills on Early-Stage Diabetic Nephropathy in db/db Mice via Inhibiting AURKB/RacGAP1/RhoA Signaling Pathway.

Authors:  Fujing Wang; Jia'er Fan; Tingting Pei; Zhuo'en He; Jiaxing Zhang; Liliang Ju; Zhongxiao Han; Mingqing Wang; Wei Xiao
Journal:  Front Pharmacol       Date:  2022-02-11       Impact factor: 5.810

6.  Heidihuangwan alleviates renal fibrosis in rats with 5/6 nephrectomy by inhibiting autophagy.

Authors:  Ying-Ying Li; Zeng-Hui Tian; Guang-Hui Pan; Ping Zhao; De-Jun Pan; Jun-Qing Zhang; Li-Ying Ye; Fa-Rong Zhang; Xiang-Dong Xu
Journal:  Front Pharmacol       Date:  2022-09-09       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.